Etiology of pyrexia in pemphigus patients: a dermatologist's enigma.
Hamideh H
HH
Qadim
Alka
A
Hasani
Bayat M
BM
Zinus
Nazila J
NJ
Orang
Akbar
A
Hasani
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000209:etiology*; D005335:Fever of Unknown Origin / Q000150:complications; D005759:Gastroenteritis / Q000150:complications / Q000382:microbiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000150:complications* / Q000188:drug therapy; D011014:Pneumonia / Q000150:complications*; D011239:Prednisolone / Q000627:therapeutic use; D013207:Staphylococcal Skin Infections / Q000150:complications*; D014552:Urinary Tract Infections / Q000150:complications*
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine